ArticleCell research2018
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models.
Zheng Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
84 papers cite itlatest 60 shown
this paperpooled ittrialcites it